IDH1 mutation detection by droplet digital PCR in glioma

Jing Wang, Yi ying Zhao, Jian feng Li, Cheng cheng Guo, Fu rong Chen, Hong kai Su, Hua fu Zhao, Ya kang Long, Jian yong Shao, Shing Shun Tony To, Zhong ping Chen

Research output: Journal article publicationJournal articleAcademic researchpeer-review

20 Citations (Scopus)


Glioma is the most frequent central nervous system tumor in adults. The overall survival of glioma patients is disappointing, mostly due to the poor prognosis of glioblastoma (Grade IV glioma). Isocitrate dehydrogenase (IDH) is a key factor in metabolism and catalyzes the oxidative decarboxylation of isocitrate. Mutations in IDH genes are observed in over 70% of low-grade gliomas and some cases of glioblastoma. As the most frequent mutation, IDH1(R132H) has been served as a predictive marker of glioma patients. The recently developed droplet digital PCR (ddPCR) technique generates a large amount of nanoliter-sized droplets, each of which carries out a PCR reaction on one template. Therefore, ddPCR provides high precision and absolute quantification of the nucleic acid target, with wide applications for both research and clinical diagnosis. In the current study, we collected 62 glioma tissue samples (Grade II to IV) and detected IDH1 mutations by Sanger direct sequencing, ddPCR, and quantitative real-time PCR (qRT-PCR). With the results from Sanger direct sequencing as the standard, the characteristics of ddPCR were compared with qRTPCR. The data indicated that ddPCR was much more sensitive and much easier to interpret than qRT-PCR. Thus, we demonstrated that ddPCR is a reliable and sensitive method for screening the IDH mutation. Therefore, ddPCR is able to applied clinically in predicting patient prognosis and selecting effective therapeutic strategies. Our data also supported that the prognosis of Grade II and III glioma was better in patients with an IDH mutation than in those without mutation.
Original languageEnglish
Pages (from-to)39651-39660
Number of pages10
Issue number37
Publication statusPublished - 1 Jan 2015


  • Droplet digital PCR (ddPCR)
  • Glioma
  • Isocitrate dehydrogenase (IDH)
  • Quantitative real-time PCR (qRT-PCR)
  • Sensitivity

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'IDH1 mutation detection by droplet digital PCR in glioma'. Together they form a unique fingerprint.

Cite this